Non-profit · founded 1944

MRIGlobal

Kansas City, United States · mriglobal.org

Manage this page

Citations, last 5 years: 377
Works, last 5 years: 83
h-index: 111
Scientists listed: 7
Grants since 2016: 111

Grants received

2024–2026 · contract · N01

PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$605.3k

2024–2029 · contract · N01

HEAL PROJECT-IHP-102

Jeanette Tombaugh · MRIGlobal · funded by National Institutes of Health

$729.9k

2024–2027 · contract · N02

MANUFACTURE OF PLASMID DNA DRUG SUBSTANCE AND DRUG PRODUCT

Rachel Ginther · MRIGlobal · funded by National Institutes of Health

$1.5M

2024–2026 · contract · N02

THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE CLINICAL TRIALS, AND

Jon White · MRIGlobal · funded by National Institutes of Health

$1.9M

2024–2025 · contract · N01

Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA)

Gene Garrard Olinger · MRIGlobal · funded by National Institutes of Health

$1.7M

2024–2029 · contract · N01

SLAUGENHAUPT-MGH DMFP FOR BPN36964 (PTC680)

Brian Penny · MRIGlobal · funded by National Institutes of Health

$1.1M

2024–2025 · contract · N01

Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS)

Michelle Kennedy · MRIGlobal · funded by National Institutes of Health

$397.8k

2024–2026 · contract · N01

PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$136.6k

2023–2025 · contract · N02

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT

Jon White · MRIGlobal · funded by National Institutes of Health

$5.2M

2023–2024 · contract · N02

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT

Jon White · MRIGlobal · funded by National Institutes of Health

$5.1M

2023–2030 · contract · N01

Task Area A: NIAID Preclinical Services for AMR Diagnostics Development

Yvette Girard · MRIGlobal · funded by National Institutes of Health

$3 500

2023–2024 · contract · N01

Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA)

Gene Garrard Olinger · MRIGlobal · funded by National Institutes of Health

$1.7MTuberculosis Research and Epidemiology

2023–2024 · contract · N01

Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS)

Michelle Kennedy · MRIGlobal · funded by National Institutes of Health

$491k

2023–2029 · contract · N01

SLAUGENHAUPT-MGH DMFP FOR BPN36964 (PTC680)

Brian Penny · MRIGlobal · funded by National Institutes of Health

$1M

2023 · contract · N01

MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)

Jeanette Coffin · MRIGlobal · funded by National Institutes of Health

$1.6M

2023–2030 · contract · N01

Task Area E: NIAID Preclinical Services for AMR Diagnostics Development

Yvette Girard · MRIGlobal · funded by National Institutes of Health

$3 500

2023–2026 · contract · N02

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT

Jon White · MRIGlobal · funded by National Institutes of Health

$5.4M

2022–2027 · contract · N01

ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND STABILITY STUDY OF ORC-13661

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$288.6k

2022 · contract · N01

MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)

Jeanette Coffin · MRIGlobal · funded by National Institutes of Health

$1.5M

2022–2027 · contract · N01

ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND STABILITY STUDY OF ORC-13661

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$20.6k

2022–2023 · contract · N02

STABILITY STUDIES OF ISOTOPE-SPECIFIC 2-KETOGLUTARIC ACID

Jonathan White · MRIGlobal · funded by National Institutes of Health

$49k

2021–2022 · contract · N02

PERFORM DEVELOPMENTAL STUDIES OF ISOTOPE-SPECIFIC 2-KETOGLUTARIC ACID.

Jonathan White · MRIGlobal · funded by National Institutes of Health

$61.3k

2021–2023 · contract · N02

THE OBJECTIVE OF THIS TASK ORDER IS TO PERFORM DEVELOPMENTAL STUDIES OF ISOTOPE-SPECIFIC 2-KETOGLUTARIC ACID.

Jonathan White · MRIGlobal · funded by National Institutes of Health

$7 811

2021 · contract · N01

MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)

Jeanette Coffin · MRIGlobal · funded by National Institutes of Health

$1.5M

2021–2022 · contract · N01

Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS)

Michelle Kennedy · MRIGlobal · funded by National Institutes of Health

$463.8k

2021–2023 · contract · N01

Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS)

Michelle Kennedy · MRIGlobal · funded by National Institutes of Health

$477.2k

2020–2024 · contract · N01

MRIGLOBAL - WAGNER DMFP

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$958.9k

2020 · contract · N01

MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)

Jeanette Coffin · MRIGlobal · funded by National Institutes of Health

$1.5M

2020–2024 · contract · N01

MRIGLOBAL - WAGNER DMFP

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$263.1k

2020–2022 · research · Global Health

MRIGlobal - to establish virtual training modules for laboratory and data analytics work related to COVID-19 genomic epidemiology

MRIGlobal · funded by Bill and Melinda Gates Foundation

$249.8k

2020–2025 · contract · N01

MRIGLOBAL - WAGNER DMFP

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$313.5k

2019 · contract · N01

MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)

Jeanette Coffin · MRIGlobal · funded by National Institutes of Health

$1.4M

2019–2025 · contract · N01

MRI GLOBAL - MILLER DMFP

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$592.1k

2019–2027 · contract · N01

MRI GLOBAL - MILLER DMFP

Desmond Slade · MRIGlobal · funded by National Institutes of Health

$1.3M

2019–2021 · contract · N02

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT

Charles Allen · MRIGlobal · funded by National Institutes of Health

$4M

2019–2022 · research · R43

Cost effective nutritional therapy for managing sickle cell disease complications

Jonathan K. Stiles · MRIGlobal · funded by National Institutes of Health

$294kHemoglobinopathies and Related Disorders

2019–2020 · contract · N02

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT

Charles Allen · MRIGlobal · funded by National Institutes of Health

$3.9M

2019–2022 · contract · N02

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT

Charles Allen · MRIGlobal · funded by National Institutes of Health

$4.1M

2019–2023 · contract · N02

CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT

Charles Allen · MRIGlobal · funded by National Institutes of Health

$5.4M

2018–2021 · contract · N01

MIDWEST RESEARCH INSTITUTE:1107561 [18-013091]

Charles Allen · MRIGlobal · funded by National Institutes of Health

$65k